These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5333324)

  • 21. Vasodilator action of Stugeron on the cerebral and peripheral arteries in the light of clinical observations.
    Less E
    Ther Hung; 1973; 21(3-4):140-5. PubMed ID: 4806424
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prevention, therapy and rehabilitation in cerebral blood circulation disorders].
    Fliege K
    Z Allgemeinmed; 1972 Jun; 48(18):857-60. PubMed ID: 4649642
    [No Abstract]   [Full Text] [Related]  

  • 23. Open-labeled phase III clinical trials with vinpocetine in Japan.
    Ebi O
    Ther Hung; 1985; 33(1):41-9. PubMed ID: 3915913
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of peripheral vasodilator drug in peripheral and cerebrovascular syndromes of old age].
    Andalò L; Missana M
    Clin Ter; 1975 Sep; 74(5):471-84. PubMed ID: 819202
    [No Abstract]   [Full Text] [Related]  

  • 25. [Possibility of improvement of cerebral function under the effect of prolonged combined infusions-injections oral therapy in geriatrics].
    Engel K; Pramer I
    Wien Med Wochenschr; 1971 Apr; 121(14):269-72. PubMed ID: 4397767
    [No Abstract]   [Full Text] [Related]  

  • 26. [Determinants estimating cerebral functions after long term therapy with hydergin].
    Herzfeld U; Christian W; Ronge J; Wittgen M
    Arztl Forsch; 1972 Jun; 26(6):215-28. PubMed ID: 4626216
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effectiveness of vasoactive preparations in patients with circulatory encephalopathy].
    Petelin LS; Shtok VN; Fedorova NV
    Klin Med (Mosk); 1988 Sep; 66(9):67-9. PubMed ID: 3204964
    [No Abstract]   [Full Text] [Related]  

  • 28. [Benfurodil hemisuccinate in cerebrovascular pathology].
    Lehembre P; Warot P
    Lille Med; 1974 Apr; 19(4 Suppl 11):525-7. PubMed ID: 4612281
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of cyclandelate on cerebral cortex perfusion-rates in cerebrovascular disease.
    O'Brien MD; Veall N
    Lancet; 1966 Oct; 2(7466):729-30. PubMed ID: 4162060
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of ACTH on behavior of the acidophilic leukocytes and leukergia in peripheral blood of patients after cerebral apoplexy].
    Kawiak W; Maksymowicz B
    Neurol Neurochir Pol; 1968; 2(2):185-90. PubMed ID: 4302347
    [No Abstract]   [Full Text] [Related]  

  • 31. [Double-blind study based upon a quatitative appreciation scale of treating chronic cerebrovascular disorders].
    Mémin Y; Najean Hueber E
    Therapeutique; 1973 Nov; 49(9):605-8. PubMed ID: 4600040
    [No Abstract]   [Full Text] [Related]  

  • 32. Cerebrovascular lesions. Active antihypertensive treatment and the present situation.
    Frithz G; Hood B; Hansson L; Björk S
    Acta Med Scand; 1974; 196(1-2):35-8. PubMed ID: 4418225
    [No Abstract]   [Full Text] [Related]  

  • 33. [New aspects in the therapy of cerebrovascular diseases. Hemodynamic studies with a combination of coumarin-rutin-theophylline].
    Klein K
    Arzneimittelforschung; 1974 Jul; 24(7):1066-9. PubMed ID: 4408076
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical and thermometric study of Surheme in 30 cases of cerebrovascular disorders].
    Balmes A; Piglowski J
    Therapeutique; 1973; 49(5):361-7. PubMed ID: 4781830
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of vascular diseases of the nervous system with Viquidil hydrochloride].
    Boudouresques J; Gosset A
    Mars Med; 1972; 109(6):453-6. PubMed ID: 4563604
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of tardokrein in vascular diseases of the nervous system].
    Wasilewski R; Rubach K; Bortnowska M
    Neurol Neurochir Pol; 1972; 6(5):855-60. PubMed ID: 4655989
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical, rheoencephalographic and ophthalmodynamographic double-blind studies of the effects of vincamine in the treatment of cerebrovascular diseases].
    Kauchtschischvili G; Nappi G; Bono G
    Minerva Med; 1974 May; 65(40):2296-315. PubMed ID: 4608671
    [No Abstract]   [Full Text] [Related]  

  • 38. [Agents to improve cerebrovascular circulation and cerebral metabolism--cellryl].
    Hasegawa T
    Nihon Rinsho; 1985 Feb; 43(2):392-6. PubMed ID: 3889413
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experiences with a hexobendine combination preparation].
    Engel K; Pramer I; Fischer M
    Wien Klin Wochenschr; 1973 Jan; 85(2):29-30. PubMed ID: 4569038
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drug-induced reaction patterns of regional cerebral blood flow (author's transl)].
    Heiss WD
    Dtsch Med Wochenschr; 1974 Feb; 99(8):323-8. PubMed ID: 4595637
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.